References
- Abd Raboh N.M., Hakim S.A.: Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. Int J Clin Exp Pathol 2015, 8, 9214–22.
- Berghloz J., Xiao Z.X.: Role of p63 in development, tumorigenesis, and cancer progression. Cancer Microenviron 2012, doi: 10.1007/s12307-012-0116-9.
- Flores E.R.: The roles of p63 in cancer. Cell Cycle 2007, doi: 10.4161/cc.6.3.3793.
- Gama A., Alves A., Gartner F., Schmitt F.: p63: a novel myoepithelial cell marker in canine mammary tissues. Vet Pathol 2003, doi: 10.1354/vp.40-4-412.
- Goldschmidt M.H., Goldschmidt K.H.: Epithelial and melanocytic tumors of the skin. In Tumors in Domestic Animals edited by Meuten D.J., John Wiley & Sons, New Jersey, 2016, pp. 113–115.
- Goldschmidt M.H., Dunstan R.W., Stannard A.A., Tscharner C.V., Walder E.J., Yager J.A.: Histological classification of epithelial and melanocytic tumors of the skin of domestic animals. WHO International Classification of Tumors of Domestic Animals, vol. 3, Armed Forces Institute of Pathology, Washington, 1998, pp. 27–28.
- Graziano V., De Laurenzi V.: Role of p63 in cancer development. Biochim Biophys Acta 2011, doi: 10.1016/j.bbcan.2011.04.002.
- Mestrinho L.A., Pissarra H., Faisca P.B., Braganca M., Peleteiro M.C., Niza M.M.: p63 and E-cadherin expression in canine oral squamous cell carcinoma. Vet Pathol 2015, 52, 614–620.
- Monteiro L.S., Delgado M.L., Ricardo S., do Amaral B., Salazar F., Pacheco J.J., Lopes C.A., Bousbaa H., Warbajykasyriya S.: Prognostic significance of CD44v6, p63, podoplanin, and MMP-9 in oral squamous cell carcinomas. Oral Dis 2016, doi: 10.1111/odi.12442.
- Nakano M., Taura Y., Inoue M.: Protein expression of Mdm2 and p53 in hyperplastic and neoplastic lesions of the canine circumanal gland. J Comp Pathol 2005, doi: 10.1016/j.jcpa.2004.06.001.
- Nekulova M., Holcakova J., Nenutil R., Stratmann R., Bouchalova P., Muller P., Moukova L., Coates P.J., Vojtesek B.: Characterization of specific p63 and p-63-N-terminal isoform antibodies and their application for immunohistochemistry. Virchows Arch 2013, 463, 415–425.
- Pereira R.S., Schweigert A., Dias de Melo G., Fernandes F.V., Sueiro F.A., Machado G.F.: Ki-67 labelling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostics and prognostic. BMC Vet Res 2013, doi: 10.1186/1746-6148-9-83.
- Petitjean A., Ruptier C., Tribollet V., Hautefeuille A., Chardon F., Cavard C., Puisieux A., Hainaut P., Caron de Fromentel C.: Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis 2008, 29, 273–281.
- Pisani G., Millanta F., Lorenzi D., Vannozzi I., Poli A.: Androgen receptor expression in normal, hyperplastic and neoplastic hepatoid glands in the dogs. Res Vet Sci 2006, doi: 10.1016/j.rvsc.2005.11.001.
- Saraiva A.L., Gartner F., Pires M.A.: Expression of p63 normal canine skin and primary cutaneous glandular carcinomas. Vet J 2008, 177, 136–140.
- Shabadash S.A., Zelikina T.I.: Once more about hepatoid circumanal glands of dogs. History of their discovery and reasons for revision the structural and functional data. Iza Akad Nauk Ser Biol 2002, 2, 176–185.
- Wilson G.P., Hayes H.M. Jr.: Castration for treatment of perianal gland neoplasms in the dog. J Am Vet Med Assoc 1979, 174, 1301–1303.
- Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F.: p63 is essential for regenerative proliferation in limb, craniofacial, and epithelial development. Nature 1999, doi: 10.1038/19539.